TAKEDA PHARMACEUTICALS AMERICA, INC.
TAKEDA PHARMACEUTICALS AMERICA, INC. is named as the registrant in 1 lobbying report we hold for 2026-Q2, for 1 client. 0 reports of 1 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA INCThe registrant lobbying for itself | 2026-Q2: $610,000 in its own lobbying expenses | 1 |
Lobbyists named in these reports
- ANDREW KAPLAN · 1 report
- KIRSTEN POWELL · 1 report
- NICHOLAS LISOWSKI · 1 report
- REBECCA MANDELL · 1 report
- SHELLEY STEWART · 1 report
Bills named, and how the House and the Senate voted
4 bills named in these reports. 1 of them became law, and our record holds how the House and the Senate voted on it. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. | Became law | Public Law 119-21House 218–214 · Senate 50–50 |
| H.R. 946ORPHAN Cures Act | Introduced | No recorded vote in our record |
| H.R. 4229To amend the Impoundment Control Act of 1974 to require prior approval from Congress before the Comptroller General may pursue a civil action under such Act, and for other purposes. | Introduced | No recorded vote in our record |
| S. 832EPIC Act of 2025 | Introduced | No recorded vote in our record |
Issues named: Budget/Appropriations (1), Defense (1), Health Issues (1), Medicare/Medicaid (1), Trade (domestic/foreign) (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA INCBudget/Appropriations, Medicare/Medicaid, Health Issues, Trade (domestic/foreign), Defense | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
| Member | Paid to, as reported | Amount | Date | Report |
|---|---|---|---|---|
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom TAKEDA PHARMACEUTICALS AMERICA INC. PAC (C00441733) | $1,000 | The report on LDA.gov |
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.